Kenneth J. Pienta
Chief Tech/Sci/R&D Officer presso James Buchanan Brady Urological Institute
Profilo
Kenneth J.
Pienta is currently the Research Director at James Buchanan Brady Urological Institute and a Professor at The Johns Hopkins University.
He previously held positions as the Director-Prostate Specialized Program at the University of Michigan, Director-Experimental Therapeutics at Michigan Center for Translational Pathology, and Independent Director at Curis, Inc. He was also a Director at GreenMark Biomedical, Inc. and is currently the Chief Medical Officer at Cue Biopharma, Inc. Pienta received his undergraduate degree from The Johns Hopkins University and his doctorate from The Johns Hopkins University School of Medicine.
Posizioni attive di Kenneth J. Pienta
Società | Posizione | Inizio |
---|---|---|
James Buchanan Brady Urological Institute | Chief Tech/Sci/R&D Officer | 01/03/2013 |
The Johns Hopkins University | Corporate Officer/Principal | 01/01/1994 |
Precedenti posizioni note di Kenneth J. Pienta
Società | Posizione | Fine |
---|---|---|
CUE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 17/01/2023 |
GreenMark Biomedical, Inc.
GreenMark Biomedical, Inc. BiotechnologyHealth Technology GreenMark Biomedical, Inc. operates as a healthcare company. It develops technologies that involve small biopolymer particles produced from food grade starch. The firm?s diagnostic product is used by dental professionals as part of the routine dental exam, assess, and monitor non-invasive treatment of dental caries. The company was founded by Steven Bloembergen in March 2016 and is headquartered in East Lansing, MI. | Director/Board Member | 01/01/2020 |
CURIS, INC. | Director/Board Member | 01/05/2017 |
Michigan Center for Translational Pathology | Corporate Officer/Principal | 01/02/2013 |
University of Michigan | Corporate Officer/Principal | - |
Formazione di Kenneth J. Pienta
The Johns Hopkins University | Undergraduate Degree |
The Johns Hopkins University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
CURIS, INC. | Health Technology |
CUE BIOPHARMA, INC. | Health Technology |
Aziende private | 2 |
---|---|
Michigan Center for Translational Pathology | |
GreenMark Biomedical, Inc.
GreenMark Biomedical, Inc. BiotechnologyHealth Technology GreenMark Biomedical, Inc. operates as a healthcare company. It develops technologies that involve small biopolymer particles produced from food grade starch. The firm?s diagnostic product is used by dental professionals as part of the routine dental exam, assess, and monitor non-invasive treatment of dental caries. The company was founded by Steven Bloembergen in March 2016 and is headquartered in East Lansing, MI. | Health Technology |
- Borsa valori
- Insiders
- Kenneth J. Pienta